{"product_id":"japan-cbd-hemp-market-report-2026-en","title":"Japan CBD \u0026 Hemp Market Report 2026 — English Edition","description":"\u003c!-- ============================================================\n     Japan CBD \u0026 Hemp Market Report 2026 — English Edition\n     Shopify product description HTML\n\n     CHANGE LOG vs. previous version\n       + Analyst question positioned as a headline benefit (3 placements)\n       + Removed the buried \"And if the report doesn't settle it\" paragraph\n       + CBN figures rewritten with explicit denominators\n       + Table of contents added\n       + Specification block added (name \/ format \/ price \/ licence \/ access)\n       + FAQ expanded: how to use the question, out-of-scope, call option\n       + Question scope tightened: one topic, asked once (3 places + 2 new FAQs)\n       - \"Don't take our word for it. Read some.\" remains removed\n       - Removed the note claiming the English Edition differs in content\n         from the Japanese Edition (not accurate — same content)\n\n     BEFORE PUBLISHING — items marked 【CONFIRM】 need your decision:\n       1. CBN denominator (search \"CONFIRM-CBN\")\n       2. Licence scope: number of named users (search \"CONFIRM-LICENCE\")\n       3. Question window: 90 days? (search \"CONFIRM-WINDOW\")\n       4. Turnaround: 5 business days? (search \"CONFIRM-TURNAROUND\")\n       5. Early-bird cutoff date (search \"CONFIRM-CUTOFF\")\n       6. Call price USD 300 (search \"CONFIRM-CALL\")\n       7. Three image URLs marked 【IMAGE】\n     ============================================================ --\u003e\n\u003cp style=\"margin: 0 0 24px;\"\u003e\u003cspan style=\"color: #ff2a00;\"\u003e\u003cstrong\u003e▲This product is digital content provided via a web page (it is not distributed as a PDF).▲\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\u003cspan style=\"font-size: 14px; color: #666;\"\u003eAfter purchase, we will send you the viewing URL and password by email. Even when updates are made, you can view the latest version using the same URL.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin: 0 0 24px;\"\u003e\u003cspan style=\"font-size: 14px; color: #666;\"\u003e※Regularly $500（¥80,000） — Now 10% OFF! Offer valid until Oct 31, 2026, 11:59 PM\u003c\/span\u003e\u003c\/p\u003e\n\u003chr style=\"border: none; border-top: 1px solid #ddd; margin: 0 0 28px;\"\u003e\n\u003ch1\u003eJapan's cannabinoid rules changed twice in 18 months. Know which side of the line your product is on — before you ship it.\u003c\/h1\u003e\n\u003cp\u003eIf you are trying to work out whether your product can enter Japan — or whether the partner in front of you is telling you the truth about the market — this is the primary research behind that decision. 168 responses from the businesses and consumers who were there when the rules changed.\u003c\/p\u003e\n\u003cp\u003eFielded Apr 20 – Jul 10, 2026 · Data as of Jul 20, 2026 · Regulatory status re-verified Aug 4, 2026 · \u003cstrong\u003eOne analyst question included\u003c\/strong\u003e\u003cbr\u003eA continuously updated web edition — not a static PDF\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eWho this is for.\u003c\/h2\u003e\n\u003cp\u003eThree kinds of people buy this report.\u003c\/p\u003e\n\u003ch3\u003eYou have a product and you want to know if it can enter Japan.\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eThe problem:\u003c\/strong\u003e The rule that decides this is written in Japanese, sits across an act, an ordinance and a ministerial notification, and changed in December 2024. The English-language coverage stops at \"Japan legalised CBD\" — which is not a sentence you can test a product against.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat you get:\u003c\/strong\u003e The limit that applies to your product form, the calculation a Japanese lab will actually perform, the seven items your COA must carry for customs pre-clearance, and the reasons compliant batches still fail market testing. Enough to run the check yourself, or to know what to ask the lab you hire.\u003c\/p\u003e\n\u003ch3\u003eA Japanese distributor or manufacturer has approached you.\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eThe problem:\u003c\/strong\u003e You cannot tell whether they are typical or unusual, whether their terms are reasonable, or whether the market behind them is growing or contracting. Nobody publishes what a Japanese CBD business actually looks like.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat you get:\u003c\/strong\u003e 55 of them, surveyed. Revenue bands, headcount, channels, margins under pressure, and what they say their biggest problem is. Plus the retailers who would stock you, and the consumers who would buy. When they tell you what the market will bear, you'll know whether it's true.\u003c\/p\u003e\n\u003ch3\u003eSomeone is asking you for a defensible view on Japan.\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eThe problem:\u003c\/strong\u003e A board, an investment committee or a client wants Asia in the deck. The public numbers disagree by a factor of five, and none of them show their working.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat you get:\u003c\/strong\u003e A primary survey with its methodology, sample sizes and known biases disclosed in full — plus every market estimate shown with the assumptions behind it. Citable, with the limitations stated so you're not defending a number you can't source.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eTwice in eighteen months.\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cstrong\u003eDecember 12, 2024\u003c\/strong\u003e\u003cbr\u003eJapan moved from part-based control to compound-based control. What matters is no longer which part of the plant it came from, but how much Δ9-THC is left in the finished product — with published, testable limits that differ by product form.\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eJune 1, 2026\u003c\/strong\u003e\u003cbr\u003eCBN became a designated substance. Manufacture, import, sale, possession and use are prohibited outside medical use. \u003cstrong\u003e23 of the 55 businesses we surveyed (41.8%)\u003c\/strong\u003e have ended or are ending CBN sales.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eJapan is not permissive. It is \u003cstrong\u003elegible\u003c\/strong\u003e. Those are different things — and for an exporter, legible is the more useful one.\u003c\/p\u003e\n\u003cp\u003eYou can read Japan's rule, test against it, and know the answer before you ship. What you cannot do is assume it will still read the same way next year. This report covers both: where the line sits today, and how it has been moving.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eThe gap only a three-sided survey can show.\u003c\/h2\u003e\n\u003cp\u003eMost industry reports survey one side of the counter. This one surveyed all three, in the same window, with the same design.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cstrong\u003eWhat the makers and sellers said the problem was\u003c\/strong\u003e\u003cbr\u003e\u003cspan style=\"font-size: 13px; color: #666;\"\u003en=55 CBD businesses\u003c\/span\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eWhat the consumers said the problem was\u003c\/strong\u003e\u003cbr\u003e\u003cspan style=\"font-size: 13px; color: #666;\"\u003en=101 consumers\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cstrong\u003e43.6%\u003c\/strong\u003e — Consumers don't understand CBD\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e19.8%\u003c\/strong\u003e — I can't tell whether the label is true\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e17.7%\u003c\/strong\u003e — I'm not sure illegal compounds haven't got in\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThese are the same problem, described from opposite ends of the counter. One side calls it an education gap. The other calls it a trust gap. Chapter 9 shows why they are the same gap — and what actually closes it.\u003c\/p\u003e\n\u003cp\u003eIf you are planning to enter Japan, this is the single most commercially useful finding in the report: it tells you what your first ¥1 of marketing should buy.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eTwelve questions this report answers.\u003c\/h2\u003e\n\u003cp\u003eEach one, with the section that answers it.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhich THC limit applies to my product — 10 ppm, 1 ppm, or 0.1 ppm?\u003c\/td\u003e\n\u003ctd\u003e§S1.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHow is total THC calculated in Japan, and does THCA count toward it?\u003c\/td\u003e\n\u003ctd\u003e§S1.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhat must appear on a COA for Japanese customs pre-clearance?\u003c\/td\u003e\n\u003ctd\u003e§S2.1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhy do compliant products still fail post-market testing in Japan?\u003c\/td\u003e\n\u003ctd\u003e§S5.1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhat exactly happened to CBN — and how fast did it happen?\u003c\/td\u003e\n\u003ctd\u003e§2.3.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHow did Japanese operators respond when CBN was banned?\u003c\/td\u003e\n\u003ctd\u003e§3.3.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHow does Japan decide which cannabinoid to restrict next?\u003c\/td\u003e\n\u003ctd\u003e§S1.3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhat happened to the market in the weeks after the ban was announced?\u003c\/td\u003e\n\u003ctd\u003e§S1.5\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHow does Japan compare with the US, EU, UK, Germany, Switzerland, Thailand, Korea and Australia?\u003c\/td\u003e\n\u003ctd\u003eTable 7.3-1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWho is actually operating in Japan, at what scale, and through which channels?\u003c\/td\u003e\n\u003ctd\u003e§3.1, §3.4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhat can and cannot be said in Japanese advertising and on-pack?\u003c\/td\u003e\n\u003ctd\u003e§S2.3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWhy do Japanese market-size estimates disagree by 5×, and which should I use?\u003c\/td\u003e\n\u003ctd\u003eAppendix C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003chr\u003e\u003c!-- ============ ANALYST QUESTION — PRIMARY PLACEMENT ============ --\u003e\n\u003ch2\u003eThe thirteenth question is yours.\u003c\/h2\u003e\n\u003cp\u003eThe twelve above are the ones we are asked most. Yours will not be on the list.\u003c\/p\u003e\n\u003cp\u003eEvery purchase includes \u003cstrong\u003eone question, put to the research team and answered in writing\u003c\/strong\u003e — from the ordinance, the notification, the survey data, or the laboratory practice behind them, with the source cited.\u003c\/p\u003e\n\u003cp\u003eMost of what we are asked is a version of: \u003cem\u003edoes this limit apply to my product form?\u003c\/em\u003e That is exactly the question a report can leave you halfway to answering.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat we will do:\u003c\/strong\u003e identify the rule that governs your case, show the calculation, cite the source with its retrieval date, and tell you what a Japanese laboratory or customs broker will be looking for.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat we will not do:\u003c\/strong\u003e tell you your product is legal. That is a determination for Japanese counsel — and anyone who gives it to you in an email is not helping you.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOne question, on one topic, asked once.\u003c\/strong\u003e Pick the point that matters most — a single product form, a single compound, a single regulatory requirement — and we will answer it properly. This is not a retainer and not an ongoing thread. If you send a list, we will ask you which one you would like answered.\u003c\/p\u003e\n\u003cp\u003eAsk in English or Japanese by July 31, 2027, via our online form. Simply select \"Market Entry Consultation\" and include your Order Number. There are no strict requirements regarding the nature of your inquiry, as long as it focuses on one specific question. Your question is never published and never attributed.\u003c\/p\u003e\n\u003cp\u003eSample written response from the research team, with sources cited and identifying details redacted\u003c\/p\u003e\n\u003ch3\u003eHow it works\u003c\/h3\u003e\n\u003cp\u003eThree steps: purchase, submit via form, receive a written answer with sources\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e01\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBuy the English Edition. Your access email arrives with your Order Number, URL, and password.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e02\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGo to the \u003ca href=\"https:\/\/whitepaper.asabis.co.jp\/en\/2026#contact\" title=\"Inquiry Form\" rel=\"noopener\" target=\"_blank\"\u003eInquiry Form\u003c\/a\u003e, select \"Market Entry Consultation\" as the Inquiry Type, and enter your Order Number along with your question (1 question per purchase).\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e03\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eThe research team answers in writing via email or chat with sources, typically within five business days.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp style=\"border-left: 4px solid #5e673c; padding: 14px 18px; background: #f6f6f1;\"\u003eFree of charge for buyers. Valid until July 31, 2027.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eResidual Δ9-THC limits in Japan\u003c\/h2\u003e\n\u003cp\u003eIn force since December 12, 2024. Three limits, by product form.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10 ppm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOils liquid at room temperature, and powders\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e1 ppm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEverything else — gummies, tablets, vapes\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e0.1 ppm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAqueous solutions\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eTotal Δ9-THC = Δ9-THC + (0.877 × Δ9-THCA).\u003c\/strong\u003e A certificate reporting Δ9-THC alone does not answer the question.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eWhat it costs to get this wrong.\u003c\/h2\u003e\n\u003cp\u003eA product over the limit is not \"non-compliant\" in Japan. It is a \u003cstrong\u003enarcotic\u003c\/strong\u003e. The classification is automatic, and it does not care what the product was sold as.\u003c\/p\u003e\n\u003cp\u003eClearing customs is not the end of the exposure. The Ministry of Health and the prefectures buy finished products off the shelf and test them. Between May 2025 and April 2026, \u003cstrong\u003efour public warnings covering five products\u003c\/strong\u003e were issued for exceeding the residual limit. The forms were gummies, a drink, a wax and a liquid — no single category was spared. In one case the ministry bought the products itself; in another, the prefecture named the distributor and the manufacturing site, ordered sales stopped, and asked consumers holding the product to hand it in.\u003c\/p\u003e\n\u003cp\u003eEach of those products had a supply chain behind it. Someone had sourced the raw material, someone had manufactured, someone had imported, and someone had put their name on the label.\u003c\/p\u003e\n\u003cp\u003eNone of it turns on intent. It turns on a number — and on whether the number you tested is the number a regulator will find.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThe enforcement record is set out in §7.1.3, with the testing practice that produces these failures in §S5.1.\u003c\/em\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eThree things you get.\u003c\/h2\u003e\n\u003ch3\u003e1. Work out whether your product qualifies\u003c\/h3\u003e\n\u003cp\u003eJapan replaced part-based regulation with compound-based regulation in December 2024. Most English-language coverage stopped there. This report goes to the operating detail.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eProduct-form THC limits — and why the same extract can be legal in one format and narcotic in another\u003c\/li\u003e\n\u003cli\u003eTotal THC: the 0.877 conversion factor, and how THCA is folded in\u003c\/li\u003e\n\u003cli\u003eThe two-track system — narcotic versus designated substance — and how a compound gets promoted from one to the other\u003c\/li\u003e\n\u003cli\u003eThe C3–C8 side-chain logic that makes the next ban predictable rather than surprising\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eSections 2.3 and Special Feature 1 · 8 jurisdictions compared in Table 7.3-1\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003e2. See what the market did when the rules changed\u003c\/h3\u003e\n\u003cp\u003eNot opinion. Response distributions from 55 CBD businesses, 12 hemp businesses and 101 consumers.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e40.4%\u003c\/strong\u003e of respondents carried CBN at all. Of the full sample of 55, \u003cstrong\u003e41.8%\u003c\/strong\u003e have ended or are ending CBN sales \u003c!-- CONFIRM-CBN: state the denominator for 40.4% (n=47?). If 40.4% is a share of a sub-sample, name it here explicitly. --\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e61.8%\u003c\/strong\u003e name regulatory compliance as their single largest burden — up from 5th place a year earlier (n=55)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e43.6%\u003c\/strong\u003e expect growth; \u003cstrong\u003e36.4%\u003c\/strong\u003e expect contraction. The market's own operators are split down the middle (n=55)\u003c\/li\u003e\n\u003cli\u003eBrands are investing. Physical retail is not: \u003cstrong\u003e45%\u003c\/strong\u003e plan to hold steady, and \u003cstrong\u003ezero\u003c\/strong\u003e plan a major increase (n=20 physical retailers)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eChapters 3–6 · verbatim quotes from operators and consumers throughout\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003e3. Avoid the failures that catch compliant products\u003c\/h3\u003e\n\u003cp\u003eThe detail that decides whether your first shipment clears — and whether it survives a market test six months later.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe seven items a COA must carry for customs pre-clearance\u003c\/li\u003e\n\u003cli\u003eSelecting a testing lab — ISO\/IEC 17025, MHLW listing, and why HPLC-PDA alone can't judge a ppm-level limit\u003c\/li\u003e\n\u003cli\u003eHomogeneity and representativeness: why a compliant batch can still fail a market sample\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e841+\u003c\/strong\u003e listings of unregulated synthetics that appeared across three Japanese platforms after the CBN ban was announced\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eSpecial Features 1, 2 and 5 · including an interview with an ISO\/IEC 17025-accredited testing lab\u003c\/em\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eWhat this actually feels like from the inside.\u003c\/h2\u003e\n\u003cp\u003eThe report carries verbatim responses from the operators who answered it. This one is from a manufacturer, on the gap between holding a certificate and surviving a market test:\u003c\/p\u003e\n\u003cblockquote\u003e\n\u003cp\u003e\"We obtain a COA at the point of manufacture, and even so, we get spot-checked. If a regulated compound turns up because of degradation, we would have no choice but to exit. Honestly — I'm a little tired of being in this industry.\"\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e— CBD manufacturer, free-text response, §3.9\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003cp\u003eThat is the position 55 Japanese businesses are operating from. If you are planning to sell into that market, it is also the position your distributor, your OEM partner and your retailer are in.\u003c\/p\u003e\n\u003cp\u003eUnderstanding what they are afraid of is not sentiment. It is how you write a supply agreement they will sign.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eContents\u003c\/h2\u003e\n\u003cp\u003eNine chapters, five special features, three appendices.\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eIntroduction — scope, method, glossary\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eThe Japanese CBD and hemp market — size, structure, regulatory framework\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eCBD business survey (n=55)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eRetail and e-commerce survey (20 physical retailers \/ 11 online-only)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eHemp business survey (n=12)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eConsumer survey (n=101)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eNews and regulatory developments, Japan and abroad\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8\u003c\/td\u003e\n\u003ctd\u003eOutlook for the hemp industry — global market, sector potential, policy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9\u003c\/td\u003e\n\u003ctd\u003eConclusions and the outlook to 2027\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eS1\u003c\/td\u003e\n\u003ctd\u003eThe regulated cannabinoid list — limits, calculation, and how the next ban is decided\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eS2\u003c\/td\u003e\n\u003ctd\u003eMarket entry — COA requirements, advertising and on-pack claims\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eS3\u003c\/td\u003e\n\u003ctd\u003eOverseas CBD wellness case studies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eS4\u003c\/td\u003e\n\u003ctd\u003eSponsors, supporting associations, and the 38 named respondent companies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eS5\u003c\/td\u003e\n\u003ctd\u003eTesting practice — laboratory selection, homogeneity, and why compliant batches fail\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eA–C\u003c\/td\u003e\n\u003ctd\u003eMethodology, sampling limitations, and market estimation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003chr\u003e\n\u003ch2\u003eHow we know this.\u003c\/h2\u003e\n\u003cp\u003ePrimary survey, April 20 – July 10, 2026: 55 CBD businesses, 12 hemp businesses, 101 consumers — \u003cstrong\u003e168 responses\u003c\/strong\u003e, plus 41 AI-moderated interview sessions, open-ended and anonymous, which is how we reached operators who don't answer forms. Every quoted response is a participant's own words, recorded verbatim and reviewed by the research team before inclusion.\u003c\/p\u003e\n\u003cp\u003ePublished by a three-company committee: \u003cstrong\u003eAsabis\u003c\/strong\u003e (Japan's largest CBD and hemp community and B2B platform), \u003cstrong\u003eWellness Kit\u003c\/strong\u003e (CBD Library — seven years running Japan's largest CBD store directory), and \u003cstrong\u003eSETODEZA\u003c\/strong\u003e (CANNABIS INSIGHT — cannabis business media since 2022).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWe tell you where the data is thin.\u003c\/strong\u003e The hemp-business sample is 12 respondents. The consumer sample skews 95% toward existing users. Every market estimate discloses its assumptions and its calculation. Appendix A sets out the sampling limitations in full — before you rely on a number, you can see how it was made.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eWhat it isn't.\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIt is not legal advice.\u003c\/strong\u003e Regulation in this area changes by ministerial ordinance, sometimes in weeks. Verify with Japanese counsel before you act. This applies to the written answer to your question as much as to the report.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIt is not a definitive market-size statistic.\u003c\/strong\u003e Japan publishes no official figure for this market. We present the competing private estimates, show where they disagree by 5×, and disclose every assumption behind our own. If you need one authoritative number, no one can honestly sell you that.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIt is not a supplier directory or matchmaking service.\u003c\/strong\u003e 38 surveyed companies are named with their consent. That is a list of respondents, not an introduction.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWhat it is:\u003c\/strong\u003e the regulation decoded into operating detail, primary data on what Japanese operators and consumers actually did, and the compliance specifics that decide whether your product clears.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch2\u003eSpecification\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTitle\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eJapan CBD \u0026amp; Hemp Market Report 2026 — English Edition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePublisher\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCBD White Paper Committee (CBD Library \/ CBD-bu \/ CANNABIS INSIGHT)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePublished\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAugust 12, 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePassword-protected web edition, updated in place. Not a PDF.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLanguage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEnglish, complete edition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eData\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSurvey as of July 20, 2026 · regulatory status re-verified August 4, 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLicence\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003c!-- CONFIRM-LICENCE --\u003eSingle named user. Contact us for team or enterprise access.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eIncluded\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eOne analyst question — one topic, asked once, answered in writing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrice\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUSD 500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003chr\u003e\n\u003ch2\u003eQuestions\u003c\/h2\u003e\n\u003ch3\u003eWhat format is it? Do I get a PDF?\u003c\/h3\u003e\n\u003cp\u003eIt is a password-protected web edition, not a PDF. After purchase you receive an email with your access URL and password.\u003c\/p\u003e\n\u003ch3\u003eWhy not a PDF?\u003c\/h3\u003e\n\u003cp\u003eBecause Japan's rules moved twice in 18 months. A file downloaded today is stale the next time an ordinance is published; your access is not. The regulatory sections are updated in place for the life of your licence.\u003c\/p\u003e\n\u003ch3\u003eHow do I use my analyst question?\u003c\/h3\u003e\n\u003cp\u003eSubmit your question via our \u003ca href=\"https:\/\/whitepaper.asabis.co.jp\/en\/2026#contact\" title=\"Inquiry Form\" rel=\"noopener\" target=\"_blank\"\u003eInquiry Form \u003c\/a\u003eby July 31, 2027. Select \"Market Entry Consultation\" as the Inquiry Type, provide your Order Number, and enter your question (one question per order). This service is completely free of charge. You will receive a written response via email or chat, typically within five business days.\u003c\/p\u003e\n\u003ch3\u003eCan I ask more than one question?\u003c\/h3\u003e\n\u003cp\u003eNo. One question on one topic per purchase, asked once. If you send several, we will ask which one you would like answered. Follow-up questions are not included — if you need a longer conversation, book a call.\u003c\/p\u003e\n\u003ch3\u003eWhat counts as one topic?\u003c\/h3\u003e\n\u003cp\u003eOne product form, one compound, or one regulatory requirement. \"Which limit applies to a water-soluble beverage, and how is total THC calculated for it?\" is one topic. \"Which limits apply to my beverage, my gummy and my vape, and what does each COA need?\" is three.\u003c\/p\u003e\n\u003ch3\u003eWhat if my question is out of scope?\u003c\/h3\u003e\n\u003cp\u003eWe will tell you why, and point you to who can answer it — a Japanese law firm, a testing laboratory, or a customs broker. Your question stays unused, and you can ask a different one.\u003c\/p\u003e\n\u003ch3\u003eIs my question confidential?\u003c\/h3\u003e\n\u003cp\u003eYes. Questions are never published, never attributed, and never shared with the companies surveyed. We use them in aggregate only, to decide what the next edition should cover.\u003c\/p\u003e\n\u003ch3\u003eCan I speak to someone instead?\u003c\/h3\u003e\n\u003cp\u003eYes. A 60-minute call with the research team is available at \u003c!-- CONFIRM-CALL --\u003eUSD 300（¥50,000）, booked separately after purchase. The written question is included with the report; the call is not.\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/store.cbd-library.com\/products\/japan-market-briefing-60-minutes\" title=\"Japan Market Briefing — 60 minutes with the research team\"\u003eJapan Market Briefing — 60 minutes with the research team\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/store.cbd-library.com\/products\/japan-market-briefing-60-minutes-with-the-research-team\" title=\"Japan CBD \u0026amp; Hemp Market Report 2026 + 60-Minute Briefing\"\u003eJapan CBD \u0026amp; Hemp Market Report 2026 + 60-Minute Briefing\u003c\/a\u003e\u003c\/p\u003e\n\u003ch3\u003eHow current is the data?\u003c\/h3\u003e\n\u003cp\u003eSurvey data as of July 20, 2026. Regulatory status re-verified August 4, 2026. Every table carries its own retrieval date.\u003c\/p\u003e\n\u003ch3\u003eIs it fully in English?\u003c\/h3\u003e\n\u003cp\u003eYes. The English Edition is a complete edition, not a summary — including all tables, figures, regulatory citations and operator quotes.\u003c\/p\u003e\n\u003ch3\u003eCan I cite it in a board deck or an investor memo?\u003c\/h3\u003e\n\u003cp\u003eYes, with attribution to \u003cem\u003eJapan CBD \u0026amp; Hemp Market Report 2026, CBD White Paper Committee\u003c\/em\u003e.\u003c\/p\u003e\n\u003ch3\u003eCan I pay by invoice or purchase order?\u003c\/h3\u003e\n\u003cp\u003eYes. \u003ca href=\"https:\/\/store.cbd-library.com\/pages\/contact\" title=\"Contact us\"\u003eContact us\u003c\/a\u003e before purchase and we'll issue an invoice.\u003c\/p\u003e\n\u003ch3\u003eWhat payment methods do you accept?\u003c\/h3\u003e\n\u003cp\u003eMajor credit cards, processed by SB Payment Service.\u003c\/p\u003e\n\u003ch3\u003eDo you offer refunds?\u003c\/h3\u003e\n\u003cp\u003eDigital access is non-refundable once granted.\u003c\/p\u003e\n\u003ch3\u003eIs this legal advice?\u003c\/h3\u003e\n\u003cp\u003eNo. See \"What it isn't.\" above.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eOne analyst question included with every purchase¥\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eJapan CBD \u0026amp; Hemp Market Report 2026 — English Edition. Published by the CBD White Paper Committee (CBD Library \/ CBD-bu \/ CANNABIS INSIGHT). Survey data as of July 20, 2026; regulatory status re-verified August 4, 2026. This report is for information only and is not legal advice.\u003c\/em\u003e\u003c\/p\u003e","brand":"cbdwhitepaperproductioncommittee","offers":[{"title":"Default Title","offer_id":50039832215766,"sku":null,"price":72000.0,"currency_code":"JPY","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0624\/4597\/7814\/files\/CBD_2026.png?v=1785920196","url":"https:\/\/store.cbd-library.com\/es\/products\/japan-cbd-hemp-market-report-2026-en","provider":"CBD Library","version":"1.0","type":"link"}